Somagenetix Company
Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses. Somagenetix's mission is to use genetically modified phagocytes to treat patients suffering from immunodeficiency, neurodegeneration, and cancer with brain metastases.
Connections
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2018-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Investors:
Schroders Capital, VI Partners, Verve Ventures, Z?rcher Kantonal Bank
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Janine Reichenbach